Human Resources

The ‘Great Resignation’ and inclusion in the workplace – Report launched

Health Industry Hub | December 9, 2021 |
[Total: 1    Average: 5/5]

Human Resources: The Great Resignation is a phenomenon that describes record numbers of people leaving their jobs during the COVID-19 pandemic recovery phase. As companies navigate this challenge and re-evaluate how to retain talent, there is an urgent need for employers to focus on building workplaces that will engage and satisfy employees’ desire for more fulfilling, flexible work lives.

New research from Diversity Council Australia shows that inclusion may be exactly what employers need to future-proof their businesses as we move collectively into new ways of working.

The Inclusion@Work Index 2021-2022 maps the state of inclusion in Australian organisations and provides the Australian business case for inclusion.

More importantly, the Index highlights how workplace inclusion significantly increases performance and wellbeing, satisfaction and innovation – all factors that, when lacking, impact culture and will only contribute to the great resignation.

DCA’s Inclusion@Work Index showed the incredible impact that inclusion can have on people and culture, showing that workers in inclusive teams are:

  • 4 times less likely to leave their job in the next 12 months
  • 10 times more likely to be very satisfied
  • 4 times less likely to feel work has a negative or very negative impact on their mental health
  • 5 times less likely to experience discrimination and/or harassment
  • 11 times more likely to be highly effective than those in inclusive teams
  • 10 times more likely to be innovative
  • 6 times more likely to provide excellent customer service
  • 4 times more likely to work extra hard

Speaking about the research, DCA CEO, Lisa Annese, said “DCA is pleased to present this third Inclusion@Work Index report, which sets out the Australian business case for D&I at a critical time.

“As well as showing inclusion really matters to employees, this report also has key insights for businesses looking to make themselves more resilient to changes in the labour market as a result of COVID-19.  

“Much of Australia has experienced serious disruption to our way of life and work in the past two years. For many businesses it has involved changing the way they work; and for many employees it has changed what they are looking for from work. 

“What we are seeing internationally is that as countries are emerging from sustained pandemic restrictions, employees are expressing a desire to look for a new place to work. 

“This research demonstrates a link between non-inclusive behaviours and workers’ intentions to stay. So, if you are investing in D&I, you’re investing in the wellbeing of your people, and making your business more resilient. 

“This research also shows that Australian managers need to do better at inclusion. Less than a third of Australian workers have an inclusive manager. We need to be doing more to engage those managers, and their employees, who aren’t aware of the benefits of inclusion at work. 

“This report is a great starting point for that conversation – before it turns to mass resignations.”

Human Resources

PAIG co-chairs reflect on industry progress in D&I with sights set on next phase goals

Health Industry Hub | January 17, 2022 |

Human Resources: In this Health Industry Hub podcast, Medicines Australia’s PAIG (Pharma Australia Inclusion Group) co-chairs reflect on their contribution […]


News & Trends - Medical Technology

MedTech News -

Stryker announces fellowships for medtech partner projects

Health Industry Hub | January 17, 2022 |

MedTech News: Stryker announced two of its partner research projects have secured fellowship funding from the Australian government’s Researcher Exchange […]


News & Trends - Pharmaceuticals

Pharma News - New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

Health Industry Hub | January 17, 2022 |

Pharma News: Update to international guidelines recommend two new drugs for the treatment of COVID-19. Eli Lilly’s oral JAK inhibitor, […]


News & Trends - Pharmaceuticals

Pharma News -

Novartis shifts focus as CAR T-cell therapy fails to add benefit in non-Hodgkin lymphoma

Health Industry Hub | January 17, 2022 |

Pharma News: Novartis’ chimeric antigen receptor (CAR) T-cell therapy was not found to improve event-free survival over what was seen […]